STOCK TITAN

Peloton and Respin Health Announce First-of-Its-Kind Research Partnership to Study the Impact of Exercise on Menopause Symptoms

(Neutral)
(Very Positive)
Tags
partnership

Peloton (NYSE: PTON) and Respin Health launched a research partnership on October 6, 2025 to study how targeted exercise affects perimenopause and menopause symptoms. The PRESS study will enroll 500 Peloton members beginning October and run through December, with results due in January 2026. Participants receive free access to a curated, co-created eight-week collection of Peloton workouts and new classes designed with Respin's clinically informed menopause protocols.

The collaboration also creates a Peloton "Menopause Health" Team and will transition findings into a broader Peloton x Respin Menopause Care Program available to all Members. Enrollment opened Oct 6, 8:00 AM PT / 11:00 AM ET.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – PTON

-2.80% 1.9x vol
53 alerts
-2.80% Session close to close
-7.7% Trough in 5 hr 32 min
$3.23B Market Cap
1.9x Rel. Volume

In the Oct 6 session, PTON declined 2.80%, reflecting a moderate negative market reaction. Argus tracked a trough of -7.7% from its starting point during tracking. Our momentum scanner triggered 53 alerts that day, indicating high trading interest and price volatility. Trading volume was above average at 1.9x the daily average, suggesting increased trading activity.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Powerful Collaboration Features Co-Curated Peloton Programming Targeting the Needs of Perimenopausal and Menopausal Women

NEW YORK, Oct. 6, 2025 /PRNewswire/ -- Peloton, the global leader in connected fitness, and Respin Health, the most comprehensive platform for holistic, personalized menopause care, announce a groundbreaking partnership to advance the conversation around women's health during perimenopause and menopause. Together, the brands will partner to offer special fitness content, unite communities to empower women, and launch one of the first large-scale research studies exploring how targeted exercise can improve menopause-related symptoms, bringing scientifically validated solutions and mainstream visibility to an often-overlooked life stage.

The partnership will unfold in two key phases. Beginning this October, Peloton and Respin Health will invite 500 Peloton members to take part in an innovative research study. Aptly named 'PRESS' (Peloton/Respin Exercise & Symptoms Study), the study will provide participants with free access to a curated collection of Peloton workouts designed in collaboration with Respin Health's menopause care program, which integrates clinically informed, science-backed protocols to help manage symptoms such as sleep disruption, mood swings, and energy fluctuations. The study will run through December, with results to be shared in January 2026. Those findings will power the next phase of the partnership: the launch of the Peloton x Respin Menopause Care Program, giving women everywhere ongoing access to evidence-based exercise and menopause support.

The venture marks Peloton's inaugural curation of content specifically for menopausal women, available to all Members on the Peloton platform. The eight-week program consists of a Collection of Peloton classes and new classes co-created with Respin featuring inspiring Peloton Instructors Christine D'Ercole, Susie Chan, Joslyn Thompson Rule and Charlotte Weidenbach. To allow participants to share in community, Peloton will leverage the brand's Teams feature by creating a dedicated "Menopause Health" Team, available on the Peloton App.

"Our primary goal at Peloton is improving Member outcomes around fitness, strength, longevity and happiness," said Peter Stern, CEO Peloton. "Over the past year since I joined Peloton, I have heard from so many of our Members, including people in my own life, about the need for greater support during menopause. By partnering with Respin, we are taking an important step in supporting our Members through every phase of their wellness journey - helping them find community, build strength and feel great."

"We're getting more and more science about what works for women in perimenopause and menopause, that's amazing, but we need to take what we've learned to the streets and show how it actually works in our busy, messy, imperfect lives," said Halle Berry, Founder, Respin Health. "That's why we created this program with Peloton, the perfect partner to help us unlock the power of movement in menopause."

The collaboration launches during World Menopause Awareness Month, aligning with the International Menopause Society's 2025 theme, "Lifestyle as Medicine."

Enrollment for study participation opens October 6, 8am PT / 11am ET. To learn more about the Peloton x Respin partnership and the PRESS study, go to www.respin.health/peloton.

ABOUT RESPIN HEALTH:
Respin Health, founded by Halle Berry, hailed by Forbes as 'the new face of menopause,' was created as the first platform for holistic, personalized menopause care – meeting women exactly where they are. Going beyond symptoms to treat the whole woman, Respin Health is the only solution combining clinically-backed research, personalized care plans, dedicated coaching, peer-to-peer community, access to prescription medications including HRT, and lifestyle-as-medicine resources to empower women to take control of their menopause journey with care that surpasses traditional healthcare offerings.

ABOUT PELOTON:
Peloton (NASDAQ: PTON) provides Members with world-class equipment, ground-breaking software, expert human instruction, and the world's most supportive fitness community. Founded in 2012 and headquartered in New York City, Peloton has millions of Members across the US, UK, Canada, Germany, Australia, and Austria. For more information, visit www.onepeloton.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/peloton-and-respin-health-announce-first-of-its-kind-research-partnership-to-study-the-impact-of-exercise-on-menopause-symptoms-302575861.html

SOURCE Respin Health

FAQ

What is the Peloton PRESS study announced on October 6, 2025 (PTON)?

PRESS is a Peloton x Respin research study enrolling 500 members to test targeted exercise effects on menopause symptoms from October through December, with results in January 2026.

How can Peloton members enroll in the PRESS study (PTON) and when did enrollment open?

Enrollment opened Oct 6, 2025 at 8:00 AM PT / 11:00 AM ET; members can learn more and sign up at www.respin.health/peloton.

What will participants receive in the Peloton x Respin program (PTON)?

Participants get free access to a co-created eight-week Collection of Peloton classes and new workouts based on Respin's clinical menopause care protocols.

When will PRESS study results be published and how will they be used by Peloton (PTON)?

Results are expected in January 2026 and will inform the launch of the Peloton x Respin Menopause Care Program for all Members.

Which Peloton instructors are involved in the menopause-focused classes (PTON)?

The program features Peloton instructors Christine D'Ercole, Susie Chan, Joslyn Thompson Rule and Charlotte Weidenbach.

Will the Peloton x Respin Menopause Care Program be available to non-study Members (PTON)?

Yes; after the study and result review, Peloton plans to offer the Menopause Care Program to all Members on the Peloton platform.